发明名称 |
DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE |
摘要 |
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid in an acid or a salt form, or in a molecular complex can be used to treat or alleviate pain or related conditions. |
申请公布号 |
US2017100417(A1) |
申请公布日期 |
2017.04.13 |
申请号 |
US201615386858 |
申请日期 |
2016.12.21 |
申请人 |
ANTECIP BIOVENTURES II LLC |
发明人 |
Tabuteau Herriot |
分类号 |
A61K31/675;A61K9/00 |
主分类号 |
A61K31/675 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating chronic low back pain comprising orally administering zoledronic acid to a human being in need thereof, wherein the amount of zoledronic acid orally administered to the human being within a period of about one month is about 300 mg to about 400 mg. |
地址 |
New York NY US |